Although platelets appear by embryonic day 10.5 in the developing mouse, an embryonic
role for these cells has not been identified. The SYK–SLP-76 signaling pathway is required in …

COVID-19 is a primary respiratory illness that is frequently complicated by systemic involvement
of the vasculature. Vascular involvement leads to an array of complications ranging from …

Endothelial cells (ECs) normally form an anticoagulant surface under physiological conditions,
but switch to support coagulation following pathogenic stimuli. This switch promotes …

Background: Plasma proteins are critical mediators of cardiovascular processes and are the
targets of many drugs. Previous efforts to characterize the genetic architecture of the plasma …

Endothelial dysfunction accompanies the microvascular thrombosis commonly observed in
severe COVID-19. Constitutively, the endothelial surface is anticoagulant, a property …

Bradykinin B2 receptor–deleted mice (Bdkrb2 −/− ) have delayed carotid artery thrombosis
times and prolonged tail bleeding time resulting from elevated angiotensin II (AngII) and …

The immune receptor signaling pathway is used by nonimmune cells, but the molecular
adaptations that underlie its functional diversification are not known. Circulating platelets use the …

MicroRNAs are small noncoding RNAs that regulate cellular development by interfering
with mRNA stability and translation. We examined global microRNA expression during the …

Mammalian platelets are small, anuclear circulating cells that form tightly adherent, shear-resistant
thrombi to prevent blood loss after vessel injury. Platelet thrombi that form in coronary …

Purpose of Review This review aims to summarize the epidemiology, current pathophysiologic
understanding, and state-of-the-art treatment of venous thromboembolism (VTE) in …